Marshall Wace LLP Sells 8,118 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Marshall Wace LLP trimmed its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 33.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,913 shares of the company’s stock after selling 8,118 shares during the period. Marshall Wace LLP’s holdings in Acadia Healthcare were worth $999,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. New Mexico Educational Retirement Board raised its stake in shares of Acadia Healthcare by 18.6% during the second quarter. New Mexico Educational Retirement Board now owns 18,500 shares of the company’s stock worth $1,161,000 after buying an additional 2,900 shares during the last quarter. JPMorgan Chase & Co. increased its stake in Acadia Healthcare by 9.5% in the second quarter. JPMorgan Chase & Co. now owns 4,406,100 shares of the company’s stock valued at $276,483,000 after purchasing an additional 380,515 shares in the last quarter. Advisor Resource Council bought a new stake in Acadia Healthcare in the second quarter valued at approximately $621,000. Handelsbanken Fonder AB increased its stake in Acadia Healthcare by 22.9% in the second quarter. Handelsbanken Fonder AB now owns 15,574 shares of the company’s stock valued at $977,000 after purchasing an additional 2,900 shares in the last quarter. Finally, Amundi bought a new stake in Acadia Healthcare in the second quarter valued at approximately $284,000.

Several equities research analysts have commented on the stock. SVB Leerink assumed coverage on shares of Acadia Healthcare in a research note on Monday, September 27th. They issued an “outperform” rating and a $85.00 target price for the company. Credit Suisse Group upped their target price on shares of Acadia Healthcare from $68.00 to $69.00 and gave the company an “outperform” rating in a research note on Monday, November 1st. Barclays began coverage on shares of Acadia Healthcare in a research note on Thursday, August 12th. They issued an “underweight” rating and a $69.00 target price for the company. TheStreet upgraded shares of Acadia Healthcare from a “c+” rating to a “b” rating in a report on Monday. Finally, Cowen began coverage on shares of Acadia Healthcare in a report on Thursday, September 9th. They issued an “outperform” rating and a $79.00 price target for the company. One analyst has rated the stock with a sell rating, five have issued a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $70.79.

Shares of ACHC opened at $61.25 on Thursday. Acadia Healthcare Company, Inc. has a 12 month low of $41.68 and a 12 month high of $68.65. The firm has a fifty day simple moving average of $61.37 and a 200 day simple moving average of $62.76. The stock has a market capitalization of $5.51 billion, a price-to-earnings ratio of -8.22, a PEG ratio of 3.29 and a beta of 1.40. The company has a current ratio of 1.41, a quick ratio of 1.41 and a debt-to-equity ratio of 0.58.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, October 27th. The company reported $0.72 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.72. Acadia Healthcare had a negative net margin of 29.32% and a positive return on equity of 12.14%. The business had revenue of $587.60 million during the quarter, compared to analysts’ expectations of $591.42 million. During the same quarter in the prior year, the company posted $0.68 earnings per share. The firm’s revenue was down 29.5% on a year-over-year basis. As a group, research analysts predict that Acadia Healthcare Company, Inc. will post 2.58 earnings per share for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Co, Inc engages in the provision of behavioral healthcare services. It operates through the following business segments: United States (U.S.) Facilities and the United Kingdom (U.K.) Facilities. The U.S. Facilities segment classified in the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; residential treatment centers; and outpatient community-based services.

See Also: Why do companies issue stock splits?

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.